BRAINSTORM CELL THERAPEUTICS INC. (NASDAQ:BCLI) filed a Form 8-K with the Securities and Exchange Commission on February 13, 2026, disclosing a material event.
BRAINSTORM CELL THERAPEUTICS INC.'s stock currently trades at $0.53 with a market capitalization of $6.2M. The Healthcare company's stock moved following the disclosure.
